Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 182.82%346.25M | -37.64%330.86M | -44.16%122.43M | 72.37%530.58M | 21.99%219.25M | -24.46%307.82M | 5.85%179.73M | -20.59%407.49M | -35.17%169.79M | -13.19%513.14M |
| Special items of operating revenue | -35.65%713K | 116.34%545K | 146.24%1.11M | -579.31%-3.34M | 22.56%-2.4M | 143.15%696K | -658.33%-3.09M | -103.70%-1.61M | 87.90%-408K | --43.57M |
| Operating income | 180.86%346.96M | -37.14%331.41M | -43.03%123.53M | 70.90%527.25M | 22.77%216.86M | -23.99%308.52M | 4.28%176.63M | -27.09%405.88M | -34.48%169.38M | -5.82%556.7M |
| Cost of sales | -210.85%-323.22M | 40.24%-287.11M | 49.06%-103.98M | -76.49%-480.43M | -29.76%-204.14M | 19.45%-272.21M | -12.37%-157.33M | 29.20%-337.93M | 41.11%-140.01M | 11.50%-477.27M |
| Operating expenses | -210.85%-323.22M | 40.24%-287.11M | 49.06%-103.98M | -76.49%-480.43M | -29.76%-204.14M | 19.45%-272.21M | -12.37%-157.33M | 29.20%-337.93M | 41.11%-140.01M | 11.50%-477.27M |
| Gross profit | 21.38%23.74M | -5.36%44.3M | 53.78%19.56M | 28.95%46.81M | -34.14%12.72M | -46.57%36.3M | -34.27%19.31M | -14.45%67.95M | 41.55%29.37M | 53.14%79.43M |
| Administrative expenses | -13.04%-14.8M | 2.08%-30.03M | 17.43%-13.09M | 0.37%-30.67M | 22.32%-15.85M | 9.79%-30.78M | -38.04%-20.41M | -16.76%-34.12M | -19.88%-14.78M | -6.63%-29.22M |
| Revaluation surplus | ---- | 97.39%-265K | ---- | -315.88%-10.14M | ---- | ---2.44M | ---- | ---- | ---- | ---- |
| -Changes in the fair value of investment property | ---- | 97.39%-265K | ---- | -315.88%-10.14M | ---- | ---2.44M | ---- | ---- | ---- | ---- |
| Special items of operating profit | -95.08%26K | -37.36%612K | 24.82%528K | -67.62%977K | -84.30%423K | 1,303.26%3.02M | 709.01%2.69M | -96.36%215K | -91.89%333K | 392.74%5.9M |
| Operating profit | 28.20%8.97M | 109.20%14.62M | 357.66%6.99M | 14.50%6.99M | -270.26%-2.71M | -82.07%6.1M | -89.32%1.59M | -39.33%34.05M | 19.15%14.92M | 118.67%56.11M |
| Financing cost | 1.82%-2.16M | 4.10%-4.19M | -2.23%-2.2M | -94.57%-4.37M | -197.24%-2.16M | -535.98%-2.25M | -298.35%-725K | -11.71%-353K | -8.98%-182K | 14.13%-316K |
| Earning before tax | 42.00%6.8M | 298.02%10.43M | 198.38%4.79M | -32.08%2.62M | -660.30%-4.87M | -88.55%3.86M | -94.10%869K | -39.62%33.69M | 19.28%14.74M | 120.60%55.8M |
| Tax | -403.09%-1.63M | 17.63%-1.91M | -66.15%-324K | -65.36%-2.32M | 84.13%-195K | 80.61%-1.4M | 54.83%-1.23M | -320.64%-7.24M | -54.43%-2.72M | 53.10%-1.72M |
| After-tax profit from continuing operations | 15.81%5.17M | 2,730.90%8.52M | 188.19%4.47M | -87.74%301K | -1,306.67%-5.06M | -90.72%2.46M | -103.00%-360K | -51.08%26.46M | 13.44%12.02M | 150.05%54.08M |
| Earning after tax | 15.81%5.17M | 2,730.90%8.52M | 188.19%4.47M | -87.74%301K | -1,306.67%-5.06M | -90.72%2.46M | -103.00%-360K | -51.08%26.46M | 13.44%12.02M | 150.05%54.08M |
| Minority profit | -163.39%-187K | 367.35%131K | 330.47%295K | 85.76%-49K | 36.63%-128K | 37.79%-344K | 41.11%-202K | -77.24%-553K | -130.20%-343K | ---312K |
| Profit attributable to shareholders | 28.48%5.36M | 2,297.14%8.39M | 184.50%4.17M | -87.50%350K | -3,024.05%-4.94M | -89.63%2.8M | -101.28%-158K | -50.34%27.01M | 15.06%12.36M | 151.49%54.39M |
| Basic earnings per share | 40.00%0.007 | 0.01 | 183.33%0.005 | 0 | -0.006 | -91.18%0.003 | 0 | -50.00%0.034 | 15.38%0.015 | 151.85%0.068 |
| Diluted earnings per share | 40.00%0.007 | 0.01 | 183.33%0.005 | 0 | -0.006 | -91.18%0.003 | 0 | -50.00%0.034 | 15.38%0.015 | 151.85%0.068 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.